文献
J-GLOBAL ID:202102255528429964
整理番号:21A0033544
臨床HDAC阻害剤はSARS-CoV2の侵入を防止する有効な薬剤である【JST・京大機械翻訳】
Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2
著者 (16件):
Liu Ke
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Zou Rongfeng
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Cui Wenqiang
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Cui Wenqiang
(University of Chinese Academy of Sciences, China)
,
Li Meiqing
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Li Meiqing
(University of Chinese Academy of Sciences, China)
,
Wang Xueying
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Dong Junlin
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Li Hongchun
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Li Hongpei
(College of Life Science and Technology, Jinan University, China)
,
Wang Peihui
(Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Shandong, China)
,
Shao Ximing
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Su Wu
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Chan H. C. Stephen
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Li Hongchang
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
,
Yuan Shuguang
(Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China)
資料名:
ACS Pharmacology & Translational Science
(ACS Pharmacology & Translational Science)
巻:
3
号:
6
ページ:
1361-1370
発行年:
2020年
JST資料番号:
W5671A
ISSN:
2575-9108
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)